SEBRA Sepsis and Bacterial Resistance Alliance
Organisational unit: Research group
Research areas and keywords
UKÄ subject classification
- Infectious Medicine
Sepsis is a severe, systemic response to infection, often caused by bacteria. Approx. 30 million cases occur worldwide each year causing up to 8 million deaths. The mortality is as high as 30%. Rapid and accurate diagnosis is crucial, as mortality increases with 8% every hour that appropriate treatment is delayed. Sepsis is fairly unknown to the general public, and complicated by its rapid progression and diverse etiology. Furthermore, sepsis research is underfunded in comparison to other medical conditions.
SEpsis and Bacterial Resistance Alliance (SEBRA) is an awarded cross-professional interdisciplinary group of researchers and clinicians who represent the county hospital SUS Lund, and the Faculties of Medicine and Engineering (LTH) at Lund University. SEBRAs aims are To improve the basic knowledge of the underlying molecular mechanisms of sepsis To identify molecular processes to enable improvement of sepsis diagnostics and treatment To increase awareness of sepsis To achieve a better coordination of sepsis research regionally and nationally.
Recent research outputs
HANDOC - a handy score to determine the need for echocardiography in non-beta-hemolytic streptococcal bacteremiaTorgny Sunnerhagen, Törnell, A., Vikbrant, M., Bo Nilson & Magnus Rasmussen 2018 Mar In : Clinical Infectious Diseases. 66, 5, p. 693-698 6 p.
Research output: Contribution to journal › Article
View All (33)